Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000635070 | SCV000756448 | likely benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764016 | SCV000894968 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003928065 | SCV004751017 | likely benign | CACNA1H-related condition | 2023-02-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001529534 | SCV001743131 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001529534 | SCV001800081 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529534 | SCV001967923 | likely benign | not provided | no assertion criteria provided | clinical testing |